118 related articles for article (PubMed ID: 35619282)
41. Protective Effect of Shenfu Injection on Vascular Endothelial Damage in a Porcine Model of Hemorrhagic Shock.
Zhang MQ; Zhang Q; Yuan W; Wu JY; Liang Y; Qin HJ; Li CS
Chin J Integr Med; 2022 Sep; 28(9):794-801. PubMed ID: 35023060
[TBL] [Abstract][Full Text] [Related]
42. Activated farnesoid X receptor attenuates apoptosis and liver injury in autoimmune hepatitis.
Lian F; Wang Y; Xiao Y; Wu X; Xu H; Liang L; Yang X
Mol Med Rep; 2015 Oct; 12(4):5821-7. PubMed ID: 26238153
[TBL] [Abstract][Full Text] [Related]
43. MKK4 Knockdown Plays a Protective Role in Hemorrhagic Shock-Induced Liver Injury through the JNK Pathway.
Yao H; Gao Y; Han J; Wang Y; Cai J; Rui Y; Ge X
Oxid Med Cell Longev; 2022; 2022():5074153. PubMed ID: 36164393
[TBL] [Abstract][Full Text] [Related]
44. Fuzheng Huayu recipe alleviates hepatic fibrosis via inhibiting TNF-α induced hepatocyte apoptosis.
Tao YY; Yan XC; Zhou T; Shen L; Liu ZL; Liu CH
BMC Complement Altern Med; 2014 Nov; 14():449. PubMed ID: 25407538
[TBL] [Abstract][Full Text] [Related]
45. [Suppression of HMGB1 inhibits neuronal autophagy and apoptosis to improve neurological deficits in rats following intracerebral hemorrhage].
Zhang L; Miao S; Yang Z; Li Z; Fan Y; Yu K; Huang K; Huang Q; Xia X
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jul; 42(7):1050-1056. PubMed ID: 35869769
[TBL] [Abstract][Full Text] [Related]
46. Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity.
Buryova H; Chalupsky K; Zbodakova O; Kanchev I; Jirouskova M; Gregor M; Sedlacek R
BMC Gastroenterol; 2013 Oct; 13():155. PubMed ID: 24172289
[TBL] [Abstract][Full Text] [Related]
47. The effect of ursodeoxycholic acid on the relative expression of the lipid metabolism genes in mouse cholesterol gallstone models.
Fan N; Meng K; Zhang Y; Hu Y; Li D; Gao Q; Wang J; Li Y; Wu S; Cui Y
Lipids Health Dis; 2020 Jul; 19(1):158. PubMed ID: 32615989
[TBL] [Abstract][Full Text] [Related]
48. Ursodeoxycholyl lysophosphatidylethanolamide protects against hepatic ischemia and reperfusion injury in mice.
Wang J; Deng X; Yi S; Pathil A; Zhang W; Setchell K; Stremmel W; Chamulitrat W
Shock; 2015 Apr; 43(4):379-86. PubMed ID: 25526375
[TBL] [Abstract][Full Text] [Related]
49. HMGB1 Neutralizing Antibody Attenuates Cardiac Injury and Apoptosis Induced by Hemorrhagic Shock/Resuscitation in Rats.
Zhou Y; Li Y; Mu T
Biol Pharm Bull; 2015; 38(8):1150-60. PubMed ID: 26040987
[TBL] [Abstract][Full Text] [Related]
50. Caspase-1 is hepatoprotective during trauma and hemorrhagic shock by reducing liver injury and inflammation.
Menzel CL; Sun Q; Loughran PA; Pape HC; Billiar TR; Scott MJ
Mol Med; 2011; 17(9-10):1031-8. PubMed ID: 21666957
[TBL] [Abstract][Full Text] [Related]
51. The protective effects of ursodeoxycholic acid on isoniazid plus rifampicin induced liver injury in mice.
Chen X; Xu J; Zhang C; Yu T; Wang H; Zhao M; Duan ZH; Zhang Y; Xu JM; Xu DX
Eur J Pharmacol; 2011 May; 659(1):53-60. PubMed ID: 21419764
[TBL] [Abstract][Full Text] [Related]
52. Mechanism for hepato-protective action of Liangxue Huayu Recipe (LHR): blockade of mitochondrial cytochrome c release and caspase activation.
Jiang ZQ; Yan XJ; Bi L; Chen JP; Zhou Q; Chen WP
J Ethnopharmacol; 2013 Jul; 148(3):851-60. PubMed ID: 23711831
[TBL] [Abstract][Full Text] [Related]
53. Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH.
Marchianò S; Biagioli M; Morretta E; Di Giorgio C; Roselli R; Bordoni M; Bellini R; Urbani G; Massa C; Monti MC; Zampella A; Distrutti E; Fiorucci S
Sci Rep; 2023 Jan; 13(1):1602. PubMed ID: 36709356
[TBL] [Abstract][Full Text] [Related]
54. Ursodeoxycholic acid suppresses eosinophilic airway inflammation by inhibiting the function of dendritic cells through the nuclear farnesoid X receptor.
Willart MA; van Nimwegen M; Grefhorst A; Hammad H; Moons L; Hoogsteden HC; Lambrecht BN; Kleinjan A
Allergy; 2012 Dec; 67(12):1501-10. PubMed ID: 23004356
[TBL] [Abstract][Full Text] [Related]
55. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation.
Rodrigues CM; Fan G; Ma X; Kren BT; Steer CJ
J Clin Invest; 1998 Jun; 101(12):2790-9. PubMed ID: 9637713
[TBL] [Abstract][Full Text] [Related]
56. [Effects of ursodeoxycholic acid on mRNA expression of MDR3 and FXR in infants with cholestatic hepatitis].
Tang Q; Wang LL; Shan QW; Yun X; Chen XQ; Deng YN
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Sep; 15(9):756-8. PubMed ID: 24034919
[TBL] [Abstract][Full Text] [Related]
57. Glucocorticoid receptor-dependent immunomodulatory effect of ursodeoxycholic acid on liver lymphocytes in mice.
Takigawa T; Miyazaki H; Kinoshita M; Kawarabayashi N; Nishiyama K; Hatsuse K; Ono S; Saitoh D; Seki S; Yamamoto J
Am J Physiol Gastrointest Liver Physiol; 2013 Sep; 305(6):G427-38. PubMed ID: 23868404
[TBL] [Abstract][Full Text] [Related]
58. Apoptotic activity of novel bile acid derivatives in human leukemic T cells through the activation of caspases.
Choi YH; Im EO; Suh H; Jin Y; Lee WH; Yoo YH; Kim KW; Kim ND
Int J Oncol; 2001 May; 18(5):979-84. PubMed ID: 11295044
[TBL] [Abstract][Full Text] [Related]
59. p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis.
Amaral JD; Castro RE; Solá S; Steer CJ; Rodrigues CM
J Biol Chem; 2007 Nov; 282(47):34250-9. PubMed ID: 17881359
[TBL] [Abstract][Full Text] [Related]
60. Ursodeoxycholic acid accelerates bile acid enterohepatic circulation.
Zhang Y; Jiang R; Zheng X; Lei S; Huang F; Xie G; Kwee S; Yu H; Farrar C; Sun B; Zhao A; Jia W
Br J Pharmacol; 2019 Aug; 176(16):2848-2863. PubMed ID: 31077342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
